Package Description

You must register for the webinar. Once you have successfully registered, you will be redirected back to this learning center where you can start the course. You will also receive an email with a link to this course.

CPA members pay $45; non-members pay $55.

Friday, January 14: Pharmacological and Psychotherapy of Anxiety: When does CBT (or other modalities) need add-on pharmacotherapy?
In this second part of a two-part series about the integration of pharmacotherapy with psychotherapy, the rationales for adding medications to psychotherapy for anxiety will be explored. Additionally, two special populations will be explored: (1) clients with co-occurring anxiety and depression, and (2) patients with co-occurring substance use disorder, in particular clients in partial or sustained recovery. Case examples will illustrate features of treatment plans utilizing specific pharmacotherapies.

Program Level: Intermediate

Learning Objectives:

1. Enumerate at least three common general medical conditions which may cause clinical levels of anxiety via their pathophysiology.
2. Classify three pharmacological treatments for anxiety based on mechanism of action; describe an empirically validated psychotherapy that could be utilized with each pharmacological approach.
3. Rank-order anxiolytics from most safe to least safe to use with persons in recovery from substance use disorders.